Association between urinary polycyclic aromatic hydrocarbons and risk of metabolic associated fatty liver disease.

Objective: To investigate the effect of urinary PAHs on MAFLD.

Methods: The study included 3,136 adults from the National Health and Nutrition Examination Survey (NHANES) conducted between 2009 and 2016. Among them, 1,056 participants were diagnosed with MAFLD and were designated as the case group.